Our Mission: Innovation Driven by Science
At Nutent Therapeutics, we're dedicated to redefining wellness through groundbreaking, scientifically validated supplements.
Born out of rigorous pharmaceutical research, our products are designed to enhance your health, vitality, and longevity with precision and purity.
The Problem We Solve
Curcumin, a potent compound derived from turmeric, has shown promise in numerous health applications, yet traditionally suffers from:
- Poor absorption and bioavailability
- Limited efficacy at typical doses
- Issues with purity and consistency in market supplements
Our Breakthrough Solution – VOLT03
We engineered VOLT03 using advanced pharmaceutical-grade Cyclodextrin-complexed curcumin technology.
This proprietary method significantly enhances the bioavailability and efficacy of curcumin, addressing critical absorption and consistency issues seen in typical supplements.
Company Background
Nutent Therapeutics was established in January 2017 as a spin-off from Levolta Pharmaceuticals, a clinical-stage company developing treatments for osteoarthritis. Founded by Richard P. Becker Jr., Ketan Desai, and Renee Stewart, Nutent Therapeutics merges deep pharmaceutical expertise with a vision to offer superior, clinically inspired nutraceutical solutions. Headquartered in Fort Lauderdale, Florida, we continuously reinvest our resources into rigorous scientific research and innovation.
Meet Our CEO – Richard P. Becker Jr., R.Ph., M.B.A.
Richard P. Becker Jr. brings over two decades of pharmaceutical leadership experience to Nutent Therapeutics. His distinguished career spans executive roles at Alcon, Merck, Novartis, OSI Pharmaceuticals, Bayer, and BASF. With a Master's degree from Drexel University, a Bachelor of Pharmacy from Philadelphia College of Pharmacy & Sciences, and an Executive Management certificate from Wharton Business School, Richard drives Nutent's vision with unparalleled industry expertise and strategic insight.
